The market was valued at $25.2 billion in 2012 and is expected to grow at a compound annual growth rate of 4.1 percent from 2013 to 2019. Polymers are estimated to grow at the fastest growth rate between 2013 and 2019.
Some of the major companies operating in the biomaterials market include Biomet, Ceradyne, Collagen Matrix, Evonik Industries and Invibio.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
